0
Login
Home Credit Perspective Reports Naari Pharma Pvt. Ltd.
bg-rating-rationales

Entity-Specific Rating Rationales

21 Mar 2025

Naari Pharma Pvt. Ltd.: Ratings withdrawn

Naari Pharma Pvt. Ltd.: Ratings withdrawn

icon-download
bg-rating-crediet-reports

Entity-Specific Credit Perspective Reports

14 May 2020

Naari Pharma Pvt. Ltd.

Naari Pharma Pvt. Ltd. (Non-SF)

Ratings

Description
Short Term
Medium Term
Long Term
Issuer
Term Loan -- -- Withdrawn --
Working Capital Limits -- -- Withdrawn --
Fund-based/ Non-fund based – Working capital limits (sublimit) Withdrawn -- -- --

Our Analysts

Analyst 1

Pavethra Ponniah

Analyst 2

Mythri Macherla

Sector Head

Subrata Ray
bg-rating-research

Most Trending Research Reports

icon-prime

icon-download icon-download icon-sbscribe icon-sbscribe

View More
bg-rating-rationales

Rating Rationales
icon-download

View More

Banking Outlook: Growth and Profitability in an Uncertain Geopolitical Environment

Karthik Srinivasan,Anil Gupta,Sachin Sachdeva

22 Apr 2026 04:00 PM
Register now 18 days Left

Credit Quality Trends and ICRA’s Outlook for FY2027

Mr. K Ravichandran,Ms. Aditi Nayar,Mr. Pratik Singhania

01 Apr 2026 04:00 PM

Road sector hits a slow lane as project awarding moderates

Mr. Suprio Banerjee,Mr. M Rajashekar Reddy

25 Feb 2026 04:00 PM

PPT Icon PPT
View all

Podcast


New CPI and GDP Series | FY27 Growth and Inflation Outlook | ICRA Insight by Aditi Nayar

Mar 2026

View More

Media Release



View More
Ask Our Industry Analyst Get in touch with our Business Representative
Please enter your name
Please enter your mobile number
Please enter your email id
Please enter your company name
Name should not be greater than 50 characters
Please choose sector
Please enter your query
Query to have atleast ten characters
Query should not be greater than 1,000 characters
Please verify you are not a Robot.